Founded in 2012, Beijing Biosis Healing Biological Technology Co.,Ltd has been committed to providing advanced and comprehensive solutions for surgery and soft tissue repair. Provided innovative technology products such as regenerative surgical bio-materials, implantable soft tissue repair mesh, and intelligent minimally invasive surgical instruments with independent intellectual property rights.The self-developed SIS material was included in the National Key R&D Program (The No. 863) in the new material project of the Ministry of Science and Technology . Obtained a fund for innovation projects as a technology-based enterprise. We have got 77 national invention patents and 14 international patents, the core technologies are patented in the US, UK and Germany. Based on the core technology, a series of implantable SIS material for tissue repair have been developed, covering a number of important surgical fields such as gastrointestinal surgery, abdominal surgery, anorectal surgery, thoracic surgery, neurosurgery, orthopedics, and maxillofacial surgery.To fight against COVID-19, the company took its social responsibility to develop and produce PPE ( protective products) since Feb 2020, taking the advantages of 8000M2 clean room and rich experience of high quality control for class two and three surgical device manufacture, the company has set up production lines of full range PPE such as COVID-19 Neutralizing Antibody Detection Kit ( Colloidal Gold), surgical mask, FFP2 &FFP3 mask, Medical N95 mask, Medical protective clothing, isolation gowns, gloves etc .Products sold in over 50 countries with full CE &FDA certificates.The company has won the honors of "Top 100 Potential Enterprise of Science and Technology in China"The company will continue to develop more advanced technologies and innovative products, and promote advanced clinical technology and treatment concepts together with clinical experts. Make unremitting efforts to improve the quality of human lives.